These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18242705)

  • 1. Ovine anti-rabies antibody production and evaluation.
    Redwan el-RM; Fahmy A; El Hanafy A; Abd El-Baky N; Sallam SM
    Comp Immunol Microbiol Infect Dis; 2009 Jan; 32(1):9-19. PubMed ID: 18242705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli.
    Motoi Y; Sato K; Hatta H; Morimoto K; Inoue S; Yamada A
    Vaccine; 2005 Apr; 23(23):3026-32. PubMed ID: 15811649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.
    Lang J; Attanath P; Quiambao B; Singhasivanon V; Chanthavanich P; Montalban C; Lutsch C; Pepin-Covatta S; Le Mener V; Miranda M; Sabchareon A
    Acta Trop; 1998 Jul; 70(3):317-33. PubMed ID: 9777717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine.
    Turner GS
    J Gen Virol; 1978 Sep; 40(3):595-604. PubMed ID: 690611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit anti-rabies immunoglobulins production and evaluation.
    Liu X; Liu Q; Feng X; Tang Q; Wang Z; Li S; Feng Z; Zhu J; Guan X
    Trop Biomed; 2011 Apr; 28(1):138-48. PubMed ID: 21602780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
    Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of purified Vero-cell rabies vaccine in severely rabies-exposed patients in China.
    Wang XJ; Lang J; Tao XR; Shu JD; Le Mener V; Wood SC; Huang JT; Zhao SL
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):287-94. PubMed ID: 11127328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
    Dong G; Zheng H; Liu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
    Quiambao BP; Lang J; Vital S; Montalban CG; Le Mener V; Wood SC; Miranda E
    Acta Trop; 2000 Feb; 75(1):39-52. PubMed ID: 10708006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C
    Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immune globulin.
    Goel SK; Sharma S; Singh US
    Biologicals; 2003 Dec; 31(4):233-6. PubMed ID: 14624792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].
    Thraenhart O; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies.
    Muhamuda K; Madhusudana SN; Ravi V
    Hum Vaccin; 2007; 3(5):192-5. PubMed ID: 17637573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
    Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
    Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts.
    Tantawichien T; Jaijaroensup W; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Nov; 33(10):E122-4. PubMed ID: 11641838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.